Literature DB >> 10960470

Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA.

R Delage-Mourroux1, P G Martini, I Choi, D M Kraichely, J Hoeksema, B S Katzenellenbogen.   

Abstract

The transcriptional activity of nuclear hormone receptors is known to be modulated by coregulator proteins. We found that the repressor of estrogen receptor activity (REA), a protein recruited to the hormone-occupied estrogen receptor (ER), decreased the transcriptional activity of ER, both when ER was acting directly through DNA response elements as well as when it was tethered to other transcription factors. Administration of antisense REA resulted in a 2-4-fold increase in ER transactivation, implying that endogenous REA normally dampens the stimulatory response to estradiol. To define the interaction regions between ER and REA, we used glutathione S-transferase pull-down assays. We found that REA bound to the ligand-binding domain (E domain) of ER, but not to other regions of ER, and that REA interaction with ER involved a region in the C-terminal half of REA. REA and the coactivator SRC-1 were involved in a functional competition for regulation of ER transcriptional activity, which we show results from competition between these two coregulators for interaction with ER. REA contains an LXXLL motif near its N terminus, but this motif was not involved in its binding to ER. Rather, this sequence was required for the competitive binding of REA and SRC-1 to ER and thus for optimal repression of ER activity. Our findings show that the regions of REA required for its interaction with ER and for its repression of ER activity are different.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960470     DOI: 10.1074/jbc.M001327200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland.

Authors:  Paola Mussi; Lan Liao; Seong-Eun Park; Paolo Ciana; Adriana Maggi; Benita S Katzenellenbogen; Jianming Xu; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-25       Impact factor: 11.205

Review 2.  Corepressors of agonist-bound nuclear receptors.

Authors:  Igor Gurevich; Anthony M Flores; Brian J Aneskievich
Journal:  Toxicol Appl Pharmacol       Date:  2007-06-14       Impact factor: 4.219

3.  PHB2 interacts with RNF2 and represses CP2c-stimulated transcription.

Authors:  Sun-Joo Lee; Dongwon Choi; Hyangshuk Rhim; Hyo-Jung Choo; Young-Gyu Ko; Chul Guen Kim; Seongman Kang
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

4.  Uterine development and fertility are dependent on gene dosage of the nuclear receptor coregulator REA.

Authors:  Sunghee Park; Sangyeon Yoon; Yuechao Zhao; Seong-Eun Park; Lan Liao; Jianming Xu; John P Lydon; Francesco J DeMayo; Bert W O'Malley; Milan K Bagchi; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2012-05-14       Impact factor: 4.736

5.  Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo.

Authors:  Seong-Eun Park; Jianming Xu; Antonina Frolova; Lan Liao; Bert W O'Malley; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice.

Authors:  Sunghee Park; Yuechao Zhao; Sangyeon Yoon; Jianming Xu; Lan Liao; John Lydon; Franco DeMayo; Bert W O'Malley; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

7.  Estradiol inhibits Th17 cell differentiation through inhibition of RORγT transcription by recruiting the ERα/REA complex to estrogen response elements of the RORγT promoter.

Authors:  Rong-Yi Chen; Yi-Ming Fan; Qiuyang Zhang; Sen Liu; Qingli Li; Guo-Lin Ke; Chen Li; Zongbing You
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

Review 8.  Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.

Authors:  Jing Peng; Surojeet Sengupta; V Craig Jordan
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

9.  Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2.

Authors:  Christopher C Williams; Aninda Basu; Abeer El-Gharbawy; Latonya M Carrier; Carolyn L Smith; Brian G Rowan
Journal:  BMC Biochem       Date:  2009-12-31       Impact factor: 4.059

10.  RIP140 in thyroid hormone-repression and chromatin remodeling of Crabp1 gene during adipocyte differentiation.

Authors:  Sung Wook Park; Wei-Hong Huang; Shawna D Persaud; Li-Na Wei
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.